Morgan Stanley Finance LLC Files 424B2 for New Securities Offering

TL;DR

**Morgan Stanley Finance LLC just filed for a new securities offering, likely to raise fresh capital.**

AI Summary

Morgan Stanley Finance LLC, a subsidiary of Morgan Stanley, filed a 424B2 prospectus on March 24, 2026, for Pricing Supplement No. 15,051. This filing indicates the offering of new securities, likely asset-backed, under their existing shelf registration (File No. 333-275587-01). For investors, this means Morgan Stanley is actively raising capital, which can be a sign of growth initiatives or managing their balance sheet, potentially impacting the company's financial leverage and future earnings.

Why It Matters

This filing signals Morgan Stanley Finance LLC is issuing new securities to raise capital, which could be used for various corporate purposes, impacting the company's financial structure and future profitability.

Risk Assessment

Risk Level: medium — The filing itself is routine for a financial institution, but the specific terms of the securities offered (not detailed here) could introduce varying levels of risk to investors.

Analyst Insight

Investors should monitor subsequent filings or press releases for details on the specific terms, interest rates, and use of proceeds for the securities offered under Pricing Supplement No. 15,051 to assess potential impact on Morgan Stanley's financial health.

Key Numbers

• 15,051 — Pricing Supplement Number (Identifies this specific offering under the shelf registration.)
• 2026-03-24 — Filing Date (The date the prospectus was filed with the SEC.)
• 333-275587-01 — Registration Statement File No. (The overarching registration under which these securities are being offered by Morgan Stanley Finance LLC.)

Key Players & Entities

• Morgan Stanley Finance LLC (company) — Filer of the 424B2 prospectus
• Morgan Stanley (company) — Parent company of the filer
• 0001666268 (person) — CIK of Morgan Stanley Finance LLC
• 0000895421 (person) — CIK of Morgan Stanley
• 333-275587-01 (dollar_amount) — File number for Morgan Stanley Finance LLC's registration statement
• 333-275587 (dollar_amount) — File number for Morgan Stanley's registration statement
• 15,051 (dollar_amount) — Pricing Supplement Number
• 2026-03-24 (dollar_amount) — Filing Date

Forward-Looking Statements

• Morgan Stanley Finance LLC will continue to utilize its shelf registration to issue new securities. (Morgan Stanley Finance LLC) — high confidence, target: 2027-03-24

FAQ

Key Financial Figures

• $1,000 — an Stanley Stated principal amount: $1,000 per security Issue price: $1,000 pe
• $250,000 — below) Aggregate principal amount: $250,000 Underliers: Invesco QQQ Trust SM ,
• $982.50 — Estimated value on the pricing date: $982.50 per security. See "Estimated Value of t
• $0.30 — eds to us (3) Per security $1,000 $0.30 $999.70 Total $250,000 $75 $2
• $999.70 — s (3) Per security $1,000 $0.30 $999.70 Total $250,000 $75 $249,925 (
• $75 — $0.30 $999.70 Total $250,000 $75 $249,925 (1) The securities will be
• $249,925 — 30 $999.70 Total $250,000 $75 $249,925 (1) The securities will be sold only
• $1,095 — appreciates 5%, investors will receive $1,095 per security, or 109.50% of the stated
• $150 — 85% of their principal and receive only $150 per security at maturity, or 15% of the

Filing Documents

• ms15051_424b2-10690.htm (424B2) — 223KB
• ex-filingfees.htm (EX-FILING FEES) — 8KB
• image1.gif (GRAPHIC) — 51KB
• image2.gif (GRAPHIC) — 89KB
• image3.gif (GRAPHIC) — 98KB
• image4.gif (GRAPHIC) — 93KB
• 0001839882-26-016778.txt ( ) — 781KB
• ex-filingfees_htm.xml (XML) — 2KB

Risk Factors

Risk Factors This section describes the material risks relating to the securities. For further discussion of these and other risks, you should read the section entitled "Risk Factors" in the accompanying product supplement and prospectus. We also urge you to consult with your investment, legal, tax, accounting and other advisers in connection with your investment in the securities. Risks Relating to an Investment in the Securities The securities do not guarantee the return of any principal and do not pay interest. The terms of the securities differ from those of ordinary debt securities in that they do not guarantee the repayment of any principal and do not pay interest. If the final level of any underlier is less than its initial level, the payout at maturity will be an amount in cash that is less, and may be significantly less, than the stated principal amount of each security, and you will lose an amount proportionate to the full decline in the level of the worst performing underlier over the term of the securities. There is no minimum payment at maturity on the securities, and, accordingly, you could lose your entire initial investment in the securities. The amount payable on the securities is not linked to the values of the underliers at any time other than the observation date. The final levels will be based on the closing levels of the underliers on the observation date, subject to postponement for non-trading days and certain market disruption events. Even if the value of each underlier appreciates prior to the observation date but then the value of any underlier drops by the observation date, the payment at maturity may be less, and may be significantly less, than it would have been had the payment at maturity been linked to the values of the underliers prior to such drop. Although the actual values of the underliers on the stated maturity date or at other times during the term of the securities may be higher than their respective closing levels on

View Full Filing

View this 424B2 filing on SEC EDGAR